What this means
This trial plans to see if silkworm pupa powder helps memory, daily tasks, nutrition, and frailty in people with Alzheimer's. It has not started, and no results have been posted yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 50–90
- Where
- 1 site
The science
- Registered title
- Silkworm Pupa Powder Improves Alzheimer's Disease
- Trial ID
- NCT07638449 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Alzheimer Disease, Sarcopenia, Asthenia, Frailty
- What is tested
- Silkworm pupa powder
- Sponsor
- Zhejiang Provincial Tongde Hospital
- Ages
- 50 Years to 90 Years
- Dates
- First posted Jun 10, 2026 · updated Jun 10, 2026
Registry summary
The goal of this clinical trial is to learn if silkworm pupa powder works to treat Alzheimer's disease in patients. It will also learn about the safety of silkworm pupa powder, and its effect on patients' nutritional and frailty status. The main questions it aims to answer are:
- Does silkworm pupa powder improve cognitive function and daily living abilities?
- Does silkworm pupa powder improve nutritional status and frailty?
- What medical problems do participants have when taking silkworm pupa powder?
Researchers will evaluate the treatment by comparing the participants' conditions after taking the powder to their baseline conditions (a single-arm study without a placebo) to see if silkworm pupa powder works to treat Alzheimer's disease.
Participants will:
- Take silkworm pupa powder every day for 12 weeks
- Visit the clinic once every 4 weeks for checkups and tests
- Use an electronic punch-card system daily and report any symptoms
Sites (1)
- Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China